ADARx Pharmaceuticals, Inc.
ADRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001802369
In the last 90 days, ADARx Pharmaceuticals, Inc. insiders filed 3 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Superinvestors holding ADRX, Q2 2026
No superinvestor reported holding ADRX in Q2 2026.